|
2024
|
Invention
|
Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof. ... |
|
|
Invention
|
Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof. Di... |
|
|
Invention
|
Penicillin-binding protein inhibitors. Described herein are certain boron-containing compounds, c... |
|
|
Invention
|
Beta-lactamase inhibitors.
Described herein are compounds and compositions that modulate the act... |
|
2023
|
G/S
|
antibiotic pharmaceutical preparation |
|
|
Invention
|
Orally-bioavailable nucleoside analogs. Described herein are orally-bioavailable nucleoside analo... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors. Disclosed herein are NLRP3 inflammasome inhibitors and composition... |
|
|
Invention
|
Orally-bioavailable nucleoside analogs.
Described herein are orally-bioavailable nucleoside anal... |
|
2022
|
Invention
|
Penicillin-binding protein inhibitors.
Described herein are certain boron-containing compounds, ... |
|
2021
|
Invention
|
Sulfonyl urea nlrp3 inflammasome inhibitors.
Disclosed herein are NLRP3 inflammasome inhibitors ... |
|
|
Invention
|
Sulfonyl urea nlrp3 inflammasome inhibitors. Disclosed herein are NLRP3 inflammasome inhibitors a... |
|
|
Invention
|
Hepatitis b capsid assembly modulators. Described herein are hepatitis B capsid assembly modulato... |
|
|
Invention
|
Process for boron-containing compounds.
Described herein are boron-containing compounds, composi... |
|
|
Invention
|
Process for boron-containing compounds. Described herein are boron-containing compounds, composit... |
|
|
Invention
|
Hepatitis b capsid assembly modulators.
Described herein are hepatitis B capsid assembly modulat... |
|
2020
|
Invention
|
Boron-containing compounds. Described herein are boron-containing compounds, compositions, and me... |
|
|
Invention
|
Broad-spectrum carbapenems.
The present disclosure provides broad-spectrum carbapenem derivative... |
|
|
Invention
|
Method for alphavirus inhibition.
Described herein are compounds that are useful in treating an ... |
|
|
Invention
|
Method for alphavirus inhibition. Described herein are compounds that are useful in treating an a... |
|
|
Invention
|
Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof.
Disclosed herein a... |
|
|
Invention
|
Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof. Disclosed herein ar... |
|
|
Invention
|
Beta-lactamase inhibitors. Described herein are compounds and compositions that modulate the acti... |
|
2019
|
G/S
|
Pharmaceutical research and development |
|
|
Invention
|
Combination compositions comprising a beta-lactamase inhibitor and uses thereof.
The present inv... |
|
|
Invention
|
Combination compositions comprising a beta-lactamase inhibitor and uses thereof. The present inve... |
|
|
Invention
|
Combination compositions comprising a beta-lactamase inhibitor.
Described herein are combination... |
|
|
Invention
|
Combination compositions comprising a beta-lactamase inhibitor. Described herein are combination ... |
|
|
Invention
|
Broad-spectrum carbapenems. The present disclosure provides broad-spectrum carbapenem derivatives... |